NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Precision Microbiota Interventions for Senoreduction Trial

Not Yet RecruitingPhase 1, Phase 2

Sponsor: Louisiana State University Health Sciences Center in New Orleans

Conditions: HIV Infections, Alcohol Drinking, Aging, Immunosenescence

Interventions: Limosilactobacillus reuteri, Blueberry extract

Countries: United States

People with HIV who drink alcohol are at increased risk for accelerated aging biology, including increased immune senescence. This randomized, double-blind, crossover clinical trial evaluates two generally recognized as safe (GRAS) microbiota-targeted interventions on immune senescence biomarkers.

Eligibility overview

Sex: ALL

Age: 40 Years to —

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Age ≥40 years
* People with HIV
* Recent alcohol use defined as ≥42 grams in the prior week and positive urine ethyl glucuronide (EtG)

Exclusion Criteria:

* Probiotic use in past 3 months
* Recent antibiotics or immunosuppressives
* Allergy to study products
* Pregnancy or breastfeeding
* Inability to comply

Locations (1)

New Orleans, Louisiana, United States